| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 07/22/2003 | US6596687 Cell adhesion inhibitors |
| 07/22/2003 | CA2294422C Tartrate salt of a substituted dipeptide |
| 07/22/2003 | CA2109320C Peptide nucleic acids |
| 07/17/2003 | WO2003057722A2 Cyclic tetrapeptide compound and use thereof |
| 07/17/2003 | WO2003057721A2 Substituted amino carboxamides for the treatment of alzheimer's disease |
| 07/17/2003 | WO2003057666A2 Inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003057200A2 Compositions comprising inhibitors of dpp-iv and nep enzymes for the treatment of diabetes |
| 07/17/2003 | WO2003057144A2 Change inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003048119A3 Method of producing n-[(2s)-sulfanyl-4-(1,5,5-trimethylhydantoinyl)butanoyl]-l-leucyl-l-tert-leucine n-methylamide and intermediate thereof |
| 07/17/2003 | WO2002083928A3 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer |
| 07/17/2003 | WO2002058589A3 Agents and methods for promoting bone growth |
| 07/17/2003 | US20030135023 Peptide structures useful for competitive modulation of dipeptidyl peptidase IV catalysis |
| 07/17/2003 | US20030134889 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 07/17/2003 | US20030134875 Production of agglomerates |
| 07/17/2003 | US20030134856 Method and structure for inhibiting activity of serine elastases |
| 07/17/2003 | US20030134802 Novel effectors of dipepetidyl peptidase IV |
| 07/17/2003 | US20030134801 Pharmaceutical compositions containing them are of the class of thrombin inhibitors which are useful as anticoagulants. |
| 07/17/2003 | US20030133953 Complexing a biologically active agent with a perturbant to reversibly transform and exposing a membrane or bilayer to the supramolecular complex |
| 07/17/2003 | US20030133927 Conjugates useful in the treatment of prostate cancer |
| 07/17/2003 | CA2472617A1 Substituted amino carboxamides for the treatment of alzheimer's disease |
| 07/17/2003 | CA2471957A1 Cyclic tetrapeptide compound and use thereof |
| 07/17/2003 | CA2471204A1 Inhibitors of dipeptidyl peptidase iv |
| 07/16/2003 | EP1327146A2 Compounds with a branched linker |
| 07/16/2003 | EP1326851A1 Substituted dipeptides as growth hormone secretagogues |
| 07/16/2003 | EP1326840A2 Substituted heterocyclic compounds for treating multidrug resistance |
| 07/16/2003 | EP1326523A2 Imaging of enzymatic activity |
| 07/16/2003 | CN1429835A Preparation method of N-carboxyalkyl dipeptide type angiotensin converting enzyme inhibitor |
| 07/16/2003 | CN1114615C Improved method for preparation of aspartame-derived compound useful as sweetener |
| 07/15/2003 | US6593459 Compound for use in the treatment of cancer |
| 07/15/2003 | US6593455 Tripeptide amides that block viral infectivity and methods of use thereof |
| 07/15/2003 | US6593454 Methods for identifying inhibitors of methionine aminopeptidases |
| 07/15/2003 | US6593300 Inhibitors of the interleukin-1 beta converting enzyme |
| 07/15/2003 | US6593295 Long lasting insulinotropic peptides |
| 07/10/2003 | WO2003055902A1 Intermediates for lhrh antagonist synthesis, process for their production, and process for lhrh antagonist production |
| 07/10/2003 | WO2003055901A1 Novel peptide sy |
| 07/10/2003 | US20030130270 Heterocyclic derivatives and their use as antithrombotic agents |
| 07/10/2003 | US20030130269 Derivatives of octahydro-6, 10-dioxo-6H-pyridazino [1,2-a] [1,2] diazepine-1-carboxylic acid, their preparation process and their use in the preparation of therapeutically active compounds |
| 07/10/2003 | US20030130204 Antipicornaviral compounds and compositons, their pharmaceutical uses, and materials for their synthesis |
| 07/10/2003 | US20030130202 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 07/10/2003 | US20030130200 Tripeptide or tetrapeptide |
| 07/10/2003 | US20030130185 Metal-binding compounds and uses therefor |
| 07/10/2003 | US20030130168 Reverse-turn mimetics and methods relating thereto |
| 07/10/2003 | US20030129722 Comprises phospholipid scramblase phosphorylated by protein kinases; antithrombotic agents |
| 07/10/2003 | US20030129675 Assaying the ability of a compound to block the binding of an alpha 4 integrin to a binding partner thereof |
| 07/09/2003 | EP1325931A1 Inhibitors of human neutrophil elastase |
| 07/09/2003 | EP1325027A2 Casein peptide fragments with growth-influencing activity on cell cultures |
| 07/09/2003 | EP1325026A2 Tetrapeptide stimulating functional activity of hepatocytes and its therapeutical use |
| 07/09/2003 | EP1325025A1 Peptide-based gemini surfactant compounds facilitating the transfer into cells |
| 07/09/2003 | EP1325024A1 Selective growth media |
| 07/09/2003 | EP1324997A2 Dioxolane analogs for improved inter-cellular delivery |
| 07/09/2003 | EP1324975A2 Dynamic resolution of isomers and resolved isomers |
| 07/09/2003 | EP1224212B1 Tetrapeptide stimulating functional activity of neurones, pharmacological agent based thereon and method of use thereof |
| 07/09/2003 | EP1040096B1 Neuroprotective agents |
| 07/09/2003 | EP0964690B1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 07/09/2003 | CN1429234A Process for phoducing aspartyl dipeptide ester derivatives |
| 07/09/2003 | CN1429193A Process for producing cinnamylaldehyde derivatives, use thereof and the like |
| 07/09/2003 | CN1429121A Polyglutamic acid-camptothecin conjugates and methods of preparation |
| 07/09/2003 | CN1113895C Growth hormone secretagogues |
| 07/09/2003 | CN1113894C Process for preparing intermediates of inhibitors of enkephalinase and angiotensin coverting enzyme and intermediates thereof |
| 07/08/2003 | US6589937 Peptides and nootropic agent |
| 07/03/2003 | WO2003054146A2 Self-assembly and mineralization of peptide-amphiphile nanofibers |
| 07/03/2003 | WO2003054000A1 Template-fixed peptidomimeticsas inhibitors of serine proteases |
| 07/03/2003 | WO2003053999A2 Selective arylguanidine peptides as urokinase inhibitors |
| 07/03/2003 | WO2003053996A2 Modular peptide-based reagent |
| 07/03/2003 | WO2003053473A2 Ph-sensitive polymeric conjugates of an anthracycline drug |
| 07/03/2003 | WO2003053443A1 Substituted diketopiperazines as oxytocin antagonists |
| 07/03/2003 | WO2003053349A2 Inhibitors of hepatitis c virus |
| 07/03/2003 | WO2003053337A2 Therapeutic compositions |
| 07/03/2003 | WO2002099379A3 Breast homing peptides and methods of identifying same using aminopeptidase p |
| 07/03/2003 | WO2002072616A3 Transfection complexes |
| 07/03/2003 | US20030126648 Plasmid coding virginiae butanolide; virginiamycin; BAR receptor binding proteins |
| 07/03/2003 | US20030125565 2,5-dioxoimidazolidine or 2-thio-5-oxoimidazolidine derivatives suitable for the therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorder |
| 07/03/2003 | US20030125315 Providing a focused approach that permits a more rapid screening of probes with potential for association with a particular binding site with a higher likelihood of success; combinatorial chemistry; screening; computer software |
| 07/03/2003 | US20030125261 Administering to the mammal a therapeutically acceptable amount of a penta or hexapeptide compound to inhibit the angiogenesis |
| 07/03/2003 | US20030125260 Administering to the mammal a therapeutically acceptable amount of a tetra or pentapeptide compound to inhibit the angiogenesis |
| 07/03/2003 | US20030125240 Cyclic peptide antifungal agents |
| 07/03/2003 | US20030124120 Quinolone vitronectin receptor antagonist pharmaceuticals |
| 07/03/2003 | CA2471355A1 Substituted diketopiperazines as oxytocin antagonists |
| 07/03/2003 | CA2470976A1 Ph-sensitive polymeric conjugates of an anthracycline drug |
| 07/03/2003 | CA2470171A1 Modular peptide-based reagent |
| 07/02/2003 | EP1323729A1 Method for synthesis of (2S,3aS,7aS)-perhydroindole-2-carboxylic acid and esters thereof derivatives; and use in the synthesis of perindopril |
| 07/02/2003 | EP1323419A1 Airway mucus secretion inhibitors |
| 07/02/2003 | EP1322755A1 Human and mouse targeting peptides identified by phage display |
| 07/02/2003 | EP1322616A2 Quinoline-(c=o)-(di-, tri- and tetrapeptide) derivatives as caspase inhibitors |
| 07/02/2003 | EP1322322A2 Compounds and methods for inhibiting alpha-1 beta-1 integrins |
| 07/02/2003 | EP1226158B1 Process for preparing peptide intermediates |
| 07/02/2003 | EP0944582B1 Ketobenzamides as calpain inhibitors |
| 07/02/2003 | EP0757691B1 Cephalosporin synthesis |
| 07/02/2003 | CN1113088C Liquid detergents containing proteolytic enzyme and proptease inhibitors |
| 07/02/2003 | CN1113067C New active peptide and production thereof |
| 07/02/2003 | CN1113066C Peptide derivatives |
| 07/01/2003 | US6586630 Carbocyclic carboxy amines, used as motilin receptor antagonists for therapy of gastrointerstinal disorders such as irritable bowel syndrome; hormone inhibitors |
| 07/01/2003 | US6586602 CD antigen antagonists such as N-(methanesulfonyl)-L-prolyl-L-phenylalanine and prodrugs used as antiinflammatory agents |
| 07/01/2003 | US6586426 Pyrrolizine derivatives; thrombin, elastase, and factor X inhibitors |
| 07/01/2003 | US6586405 Non-covalent inhibitors of urokinase and blood vessel formation |
| 07/01/2003 | US6586403 Treating allergic reactions and inflammatory responses with tri-and dipeptides |
| 07/01/2003 | US6586222 Recombinant PR-3 and compositions thereof |
| 06/26/2003 | WO2003051918A1 Solution-phase process for the manufacture of decapeptide |
| 06/26/2003 | WO2003051910A2 Inhibitors of hepatitis c virus protease |
| 06/26/2003 | WO2003051848A2 Imidazolidineacetic acid derivatives |